{"id":"dfn-11","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Tremor"}]},"_chembl":{"chemblId":"CHEMBL128","moleculeType":"Small molecule","molecularWeight":"295.41"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By inhibiting PDE4, DFN-11 increases intracellular cAMP levels in inflammatory cells, leading to decreased production of pro-inflammatory cytokines and chemokines. This mechanism is intended to reduce inflammation in respiratory and inflammatory diseases. PDE4 inhibition has been explored for conditions including COPD, asthma, and other inflammatory airway diseases.","oneSentence":"DFN-11 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by suppressing cAMP degradation in immune cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:09:20.656Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT02571049","phase":"PHASE2","title":"Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2015-09","conditions":"Rapidly Escalating Migraine","enrollment":24},{"nctId":"NCT02569853","phase":"PHASE3","title":"DFN-11 Injection in Episodic Migraine With or Without Aura","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2015-09-21","conditions":"Episodic Migraine","enrollment":268},{"nctId":"NCT02583425","phase":"PHASE2","title":"Pilot Study of DFN-11 Injection in Medication Overuse Headache","status":"TERMINATED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2015-09","conditions":"Medication Overuse Headache","enrollment":27}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Sumatriptan succinate injection"],"phase":"phase_3","status":"active","brandName":"DFN-11","genericName":"DFN-11","companyName":"Dr. Reddy's Laboratories Limited","companyId":"dr-reddy-s-laboratories-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DFN-11 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by suppressing cAMP degradation in immune cells. Used for Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}